Traws Pharma advances antiviral program for hantavirus and ebola outbreaks

Go back to Traws Pharma advances antiviral program for hantavirus and ebola outbreaks
(NASDAQ: TRAW) Delayed: 0.77 -0.04 (4.94%)
Previous Close $0.81    52 Week High
Open $0.82    52 Week Low
Day High $0.85    P/E N/A 
Day Low $0.76    EPS
Volume 238,592